$Eli Lilly(LLY.US) The most direct recent impact comes from healthcare insurance and market access:

* American healthcare giants (e.g., CVS) are not including some weight-loss drugs in the Medicare reimbursement system.

* This directly affects Eli Lilly's core growth engine — weight-loss/metabolic drugs.

But don't panic, the buying point hasn't arrived yet.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.